Structural analysis and assembly of the HIV-1 Gp41 amino-terminal fusion peptide and the pretransmembrane amphipathic-At-interface sequence

Biochemistry

Volumn 45, Issue 48, 2006, Pages 14337-14346

  Lorizate, Maier ^a   De La Arada, Igor ^a   Huarte, Nerea ^a   Sánchez Martínez, Silvia ^a   De La Torre, Beatriz G ^b   Andreu, David ^b   Arrondo, José L R ^a   Nieva, José L ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; IMMUNOLOGY; INFRARED SPECTROSCOPY; INTERFACES (MATERIALS); MONOCLONAL ANTIBODIES; THERMAL EFFECTS;

AMPHIPATHIC-AT-INTERFACE SEQUENCE (AIS); CIRCULAR DICHROISM; THERMAL DENATURATION; TWO-DIMENSIONAL INFRARED CORRELATION SPECTROSCOPY;

POLYPEPTIDES;

GLYCOPROTEIN GP 41; HYBRID PROTEIN; MONOCLONAL ANTIBODY 2F5;

AMINO TERMINAL SEQUENCE; ARTICLE; CIRCULAR DICHROISM; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROPHOBICITY; INFRARED SPECTROSCOPY; MEMBRANE MODEL; MEMBRANE STABILIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN STRUCTURE; STEREOSPECIFICITY; SYNCYTIUM;

AMINO ACID SEQUENCE; ANTIBODIES; CELL MEMBRANE; CIRCULAR DICHROISM; HIV ENVELOPE PROTEIN GP41; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN CONFORMATION; PROTEIN DENATURATION; SEQUENCE ALIGNMENT; SPECTROPHOTOMETRY, INFRARED; TEMPERATURE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33845266437     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi0612521     Document Type: Article

References (55)

1. Doms, R. W., and Moore, J. P. (2000) HIV-1 membrane fusion: Targets of opportunity, J. Cell Biol. 151, F9-F14.
2. Eckert, D. M., and Kim, P. S. (2001) Mechanisms of viral fusion and its inhibition, Annu. Rev. Biochem. 70, 777-810.
3. Gallo, S. A., Finnegan, C. M., Viard, M., Raviv, Y., Dimitrov, A., Rawat, S. S., Puri, A., Durell, S., and Blumenthal, R. (2003) The HIV Env-mediated fusion reaction, Biochim. Biophys. Acta 1614, 36-50.
4. Chan, D. C., Fass, D., Berger, J. M., and Kim, P. S. (1997) Core structure of gp41 from the HIV-1 envelope glycoprotein, Cell 89, 263-273.
5. Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J., and Wiley, D. C. (1997) Atomic structure of the ectodomain from HIV-1 gp41, Nature 387, 426-428.
6. Furuta, R. A., Wild, C. T., Weng, Y., and Weiss, C. D. (1998) Capture of an early fusion-active conformation of HIV-1 gp41, Nat. Struct. Biol. 5, 276-279.
7. Muñoz-Barroso, I., Durell, S., Sakaguchi, K., Appella, E., and Blumenthal, R. (1998) Dilation of the human inmunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41, J. Cell Biol. 140, 315-323.
8. Melikyan, G. B., Markosyan, R. M., Hemmati, H., Delmedico, M. K., Lambert, D. M., and Cohen, F. S. (2000) Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion, J. Cell Biol. 151, 413-423.
9. Nieva, J. L., and Agirre, A. (2003) Are fusion peptides a good model to study viral cell fusion? Biochim. Biophys. Acta 1614, 104-115.
10. Salzwedel, K., West, J., and Hunter, E. (1999) A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for env-mediated fusion and virus infectivity, J. Virol. 73, 2469-2480.
11. Muñoz-Barroso, I., Salzwedel, K., Hunter, E., and Blumenthal, R. (1999) Role of the membrane-proximal domain in the initial stages of human immunodeficiency virus type 1 envelope glycoprotein-mediated membrane fusion, J. Virol. 73, 6089-6092.
12. Suárez, T., Gallaher, W. R., Agirre, A., Goñi, F. M., and Nieva, J. L. (2000) Membrane interface-interacting sequences within the ectodomain of the HIV-1 envelope glycoprotein: Putative role during viral fusion, J. Virol. 74, 8038-8047.
13. Sáez-Cirión, A., Nir, S., Lorizate, M., Agirre, A., Cruz, A., Pérez-Gil, J., and Nieva, J. L. (2002) Sphyngomyelin and cholesterol promote HIV-1 gp41 pretransmembrane sequence surface aggregation and membrane restructuring, J. Biol. Chem. 277, 21776-21785.
14. Sáez-Cirión, A., Arrondo, J. L. R., Gómara, M. J., Lorizate, M., Iloro, I., Melikyan, G., and Nieva, J. L. (2003) Structural and functional roles of HIV-1 gp41 pre-transmembrane sequence segmentation, Biophys. J. 85, 3769-3780.
15. Schibli, D. J., Montelaro, R. C., and Vogel, H. J. (2001) The membrane-proximal tryptophan-rich region of the HIV glycoprotein, gp41, forms a well-defined helix in dodecylphosphocholine micelles, Biochemistry 40, 9570-9578.
16. Shnaper, S., Sackett, K., Gallo, S. A., Blumenthal, R., and Shai, Y. (2004) The C- and the N-terminal regions of glycoprotein 41 ectodomain fuse membranes enriched and not enriched with cholesterol, respectively, J. Biol. Chem. 279, 18526-18534.
17. Zhu, P., Liu, J., Bess, J., Chertova, E., Lifson, J. D., Grisé, H., Ofek, G. A., Taylor, K. A., and Roux, K. H. (2006) Distribution and three-dimensional structure of AIDS envelope spikes, Nature 44, 847-852.
18. Lorizate, M., Gómara, M. J., de la Torre, B., Andreu, D., and Nieva, J. L. (2006) Membrane-transferring sequences of the HIV-1 gp41 ectodomain assemble into an immunogenic complex, J. Mol. Biol. 360, 45-55.
19. Muster, T., Steindl, F., Purtscher, M., Trkola, A., Klima, A., Himmler, G., Ruker, F., and Katinger, H. (1993) A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1, J. Virol. 67, 6642-6647.
20. Purtscher, M., Trkola, A., Gruber, G., Buchacher, A., Predl, R., Steindl, F., Tauer, C., Berger, R., Barrett, N., Jungbauer, A., et al. (1994) A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1, AIDS Res. Hum. Retroviruses 10, 1651-1658.
21. Parker, C. E., Deterding, L. J., Hager-Braun, C., Binley, J. M., Schulke, N., Katinger, H., Moore, J. P., and Tomer, K. B. (2001) Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5, J. Virol. 75, 10906-10911.
22. Barbato, G., Bianchi, E., Ingallinella, P., Hurni, W. H., Miller, M. D., Ciliberto, G., Cortese, R., Bazzo, R., Shiver, J. W., and Pessi, A. (2003) Structural analysis of the epitope of the anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion, J. Mol. Biol. 330, 1101-1115.
23. Ofek, G., Tang, M., Sambor, A., Kainger, H., Mascola, J. R., Wyatt, R., and Kwong, P. D. (2004) Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope, J. Virol. 78, 10724-10737.
24. Nieva, J. L., Nir, S., Muga, A., Goñi, F. M., and Wilschut, J. (1994) Interaction of the HIV-1 fusion peptide with phospholipid vesicles: Different structural requirements for leakage and fusion, Biochemistry 33, 3201-3209.
25. 2+-induced fusion and destabilization of liposomes, Biochemistry 24, 3099-3106.
26. Hoekstra, D., De Boer, T., Klappe, K., and Wilschut, J. (1984) Fluorescence method for measuring the kinetics of fusion between biological membranes, Biochemistry 23, 5675-5681.
27. Arrondo, J. L. R., Muga, A., Castresana, J., and Goñi, F. M. (1993) Quantitative studies of the structure of proteins in solution by Fourier-transformed infrared spectroscopy, Prog. Biophys. Mol. Biol. 59, 23-56.
28. Arrondo, J. L. R., and Goñi, F. M. (1999) Structure and dynamics of membrane proteins as studied by infrared spectroscopy, Prog. Biophys. Mol. Biol. 72, 367-405.
29. Turnay, J., Olmo, N., Gasset, M., Iloro, I., Arrondo, J. L. R., and Lizarbe, M. A. (2002) Calcium-dependent conformational rearrangements and protein stability in chicken annexin A5, Biophys. J. 83, 2280-2291.
30. 13C-enhanced Fourier transform infrared spectroscopy, Biochim. Biophys. Acta 1559, 96-120.
31. Jaroniec, C. P., Kaufman, J. D., Stahl, S. J., Viard, M., Blumenthal, R., Wingfield, P. T., and Bax, A. (2005) Structure and dynamics of micelle-associated human immunodeficiency virus gp41 fusion domain, Biochemistry 44, 16167-16180.
32. Stiegler, G., Kunert, R., Purtscher, M., Wolbank, S., Voglauer, R., Steindl, F., and Katinger, H. (2001) A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1, AIDS Res. Hum. Retroviruses 17, 1757-1765.
33. Pereira, F. B., Goñi, F. M., and Nieva, J. L. (1995) Liposome destabilization induced by the HIV-1 fusion peptide. Effect of a single amino acid substitution, FEBS Lett. 362, 243-246.
34. 10-helix is formed in water by a 13-residue peptide representing the neutralizing determinant of HIV-1 on gp41, Biochemistry 41, 12687-12696.
35. Greenfield, N. J. (1996) Methods to estimate the conformation of proteins and polypeptides from circular dichroism data, Anal. Biochem. 235, 1-10.
36. Sreerama, N., and Woody, R. W. (2004) Computation and analysis of protein circular dichroism spectra, Methods Enzymol. 383, 318-351.
37. Keating, A. E., Malashkevich, V. N., Tidor, B., and Kim, P. S. (2001) Side-chain repacking calculations for predicting structures and stabilities of heterodimeric coiled coils, Proc. Natl. Acad. Sci. U.S.A. 98, 14825-14830.
38. Litowski, J. R., and Hodges, R. S. (2002) Designing heterodimeric two-stranded α-helical coiled-coils. Effects of hydrophobicity and α-helical propensity on protein folding, stability, and specificity, J. Biol. Chem. 277, 37272-37279.
39. Perczel, A., and Fasman, G. D. (1992) Quantitative analysis of cyclic β-turn models, Protein Sci. 1, 378-395.
40. Perczel, A., and Hollósi, M. (1996) Turns, in Circular Dichroism and the Conformational Analysis of Biomolecules (Fasman, G. D., Ed.) pp 285-380, Plenum Press, New York.
41. Noda, I., Dowrey, A. E., Marcott, C., Story, G. M., and Ozaki. Y. (2000) Generalized two-dimensional correlation spectroscopy, Appl. Spectrosc. 54, 236A-248A.
42. Arrondo, J. L. R., Iloro, I., Aguirre, J., and Goñi, F. M. (2004) A two-dimensional IR spectroscopic (2D-IR) simulation of protein conformational changes, Spectroscopy 18, 49-58.
43. Iloro, I., Chehin, R., Goñi, F. M., Pajares, M. A., and Arrondo, J. L. (2004) Methionine adenosyltransferase α-helix structure unfolds at lower temperatures than β-sheet: A 2D-IR study, Biophys. J. 86, 3951-3958.
44. 10- and α-helices and β-bend ribbon structures in organic solution and in model biomembranes by Fourier transform infrared spectroscopy, Biochemistry 30, 6541-6548.
45. 10-from α-helices: Vibrational and electronic CD and IR absorption study of related Aib-containing oligopeptides, Biopolymers 65, 229-243.
46. 10-helix in aqueous solution, Biopolymers 75, 32-45.
47. McGaughey, G. B., Citron, M., Danzeisen, R. C., Freidinger, R. M., Garsky, V. M., Hurni, W. M., Joyce, J. G., Liang, X., Miller, M., Shiver, J., and Bogusky, M. J. (2003) HIV-1 vaccine development: Constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb, Biochemistry 42, 3214-3223.
48. Tian, Y., Ramesh, C. V., Ma, X., Naqvi, S., Patel, T., Cenizal, T., Tiscione, M., Diaz, K., Crea, T., Arnold, E., Arnold, G. F., and Taylor, J. W. (2002) Structure-affinity relationships in the gp41 ELDKWA epitope for the HIV-1 neutralizing monoclonal antibody 2F5: Effects of side-chain and backbone modifications and conformational constraints, J. Pept. Res. 59, 264-276.
49. Zwick, M. B., Jensen, R., Church, S., Wang, M., Stiegler, G., Kunert, R., Katinger, H., and Burton, D. R. (2005) Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1, J. Virol. 79, 1252-1261.
50. Joyce, J. G., Hurni, W. M., Bogusky, M. J., Garsky, V. M., Liang, X., Citron, M. P., Danzeisen, R. C., Miller, M. D., Shiver, J. W., and Keller, P. M. (2002) Enhancement of α-helicity in the HIV-1 inhibitory peptide DP178 leads to an increased affinity for human monoclonal antibody 2F5 but does not elicit neutralizing responses in vitro. Implications for vaccine design, J. Biol. Chem. 277, 45811-45820.
51. Perczel, A., Foxman, B. M., and Fasman, G. D. (1992) How reverse turns may mediate the formation of helical segments in proteins: An X-ray model, Proc. Natl. Acad. Sci. U.S.A. 89 (17), 8210-8214.
52. Melikyan, G. B., Egelhofer, M., and von Laer, D. (2006) Membrane-anchored inhibitory peptides capture human immunodeficiency virus type 1 gp41 conformations that engage the target membrane prior to fusion, J. Virol. 80, 3249-3258.
53. Sreerama, N., and Woody, R. W. (2000) Estimation of protein secondary structure from circular dichroism spectra: Comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set, Anal. Biochem. 287, 252-260.
54. Wimley, W. C., and White, S. H. (1996) Experimentally determined hydrophobicity scale for proteins at membrane interfaces, Nat. Struct. Biol. 3, 842-848.
55. Choisy, M., Woelk, C. H., Guégan, J., and Robertson, D. L. (2004) Comparative study of adaptive molecular evolution in different human immunodeficiency virus groups and subtypes, J. Virol. 78, 1962-1970.